Eyepoint Pharmaceuticals (EYPT) had the highest return between April 2, 2023 and May 1, 2023 by a small-cap US stock, returning 126.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Eyepoint Pharmaceuticals (EYPT) | 4/2/2023 - 5/1/2023 | 126.62% |
National CineMedia (NCMI) | 4/2/2023 - 5/1/2023 | 117.39% |
Pulse Biosciences (PLSE) | 4/2/2023 - 5/1/2023 | 98.54% |
Trevi Therapeutics (TRVI) | 4/2/2023 - 5/1/2023 | 78.34% |
X4 Pharmaceuticals (XFOR) | 4/2/2023 - 5/1/2023 | 74.44% |
American Coastal Insurance (ACIC) | 4/2/2023 - 5/1/2023 | 71.01% |
Sana Biotechnology (SANA) | 4/2/2023 - 5/1/2023 | 69.88% |
Oculis Holding AG Ordinary shares (OCS) | 4/2/2023 - 5/1/2023 | 68.36% |
Avalo Therapeutics (AVTX) | 4/2/2023 - 5/1/2023 | 66.49% |
Phathom Pharmaceuticals (PHAT) | 4/2/2023 - 5/1/2023 | 57.89% |
Immix Biopharma (IMMX) | 4/2/2023 - 5/1/2023 | 56.28% |
UroGen Pharma (URGN) | 4/2/2023 - 5/1/2023 | 55.33% |
Opus Genetics (IRD) | 4/2/2023 - 5/1/2023 | 55.15% |
Olema Pharmaceuticals (OLMA) | 4/2/2023 - 5/1/2023 | 54.7% |
Akebia Ther (AKBA) | 4/2/2023 - 5/1/2023 | 52% |
Xeris Pharmaceuticals (XERS) | 4/2/2023 - 5/1/2023 | 48.78% |
Collective Mining (CNL) | 4/2/2023 - 5/1/2023 | 48.04% |
Ovid Therapeutics (OVID) | 4/2/2023 - 5/1/2023 | 42.35% |
Annexon (ANNX) | 4/2/2023 - 5/1/2023 | 42.3% |
Cabaletta Bio (CABA) | 4/2/2023 - 5/1/2023 | 39.36% |
Bright Minds Biosciences (DRUG) | 4/2/2023 - 5/1/2023 | 39.09% |
TROOPS (TROO) | 4/2/2023 - 5/1/2023 | 36.1% |
IperionX Limited American Depositary Share (IPX) | 4/2/2023 - 5/1/2023 | 34.92% |
Magnera Corp placeholder (MAGN) | 4/2/2023 - 5/1/2023 | 32.23% |
Neurogene (NGNE) | 4/2/2023 - 5/1/2023 | 30.43% |
Small-cap stocks are treated as having a market cap between $300M and $2B.